JP2011518761A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518761A5 JP2011518761A5 JP2010535152A JP2010535152A JP2011518761A5 JP 2011518761 A5 JP2011518761 A5 JP 2011518761A5 JP 2010535152 A JP2010535152 A JP 2010535152A JP 2010535152 A JP2010535152 A JP 2010535152A JP 2011518761 A5 JP2011518761 A5 JP 2011518761A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- arabinofuranosyl
- pyrimidinone
- deoxy
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 claims 17
- 238000001990 intravenous administration Methods 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- -1 2-cyano-2-deoxy-β-D-arabinofuranosyl Chemical group 0.000 claims 7
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical compound OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 claims 7
- YCIPQJTZJGUXND-UHFFFAOYSA-N Aglaia odorata Alkaloid Natural products C1=CC(OC)=CC=C1C1(C(C=2C(=O)N3CCCC3=NC=22)C=3C=CC=CC=3)C2(O)C2=C(OC)C=C(OC)C=C2O1 YCIPQJTZJGUXND-UHFFFAOYSA-N 0.000 claims 6
- 229940034982 antineoplastic agent Drugs 0.000 claims 6
- 230000002459 sustained effect Effects 0.000 claims 4
- DCYBPMFXJCWXNB-JWIUVKOKSA-N CNDAC Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](C#N)[C@H](O)[C@@H](CO)O1 DCYBPMFXJCWXNB-JWIUVKOKSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/111,369 US7863255B2 (en) | 2008-04-29 | 2008-04-29 | Methods of administering antitumor agent comprising deoxycytidine derivative |
| US12/111,369 | 2008-04-29 | ||
| PCT/JP2009/058725 WO2009133963A1 (en) | 2008-04-29 | 2009-04-28 | Methods of administering antitumor agent comprising deoxycytidine derivative |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518761A JP2011518761A (ja) | 2011-06-30 |
| JP2011518761A5 true JP2011518761A5 (enExample) | 2012-01-26 |
| JP5570429B2 JP5570429B2 (ja) | 2014-08-13 |
Family
ID=41050984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010535152A Active JP5570429B2 (ja) | 2008-04-29 | 2009-04-28 | デオキシシチジン誘導体を含有する抗腫瘍剤を投与する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7863255B2 (enExample) |
| EP (1) | EP2268287B1 (enExample) |
| JP (1) | JP5570429B2 (enExample) |
| AU (1) | AU2009240908B2 (enExample) |
| DK (1) | DK2268287T3 (enExample) |
| ES (1) | ES2467968T3 (enExample) |
| PL (1) | PL2268287T3 (enExample) |
| WO (1) | WO2009133963A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP2014001204A (ja) * | 2012-05-23 | 2014-01-09 | Kumamoto Univ | 腫瘍細胞選択的抗がん剤 |
| CN113727719A (zh) | 2020-07-17 | 2021-11-30 | 德尔塔菲制药股份有限公司 | 血癌的新型治疗方法及新型治疗剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| GB0328180D0 (en) * | 2003-12-04 | 2004-01-07 | Cyclacel Ltd | Combination |
| GB0609530D0 (en) * | 2006-05-12 | 2006-06-21 | Cyclacel Ltd | Combination |
-
2008
- 2008-04-29 US US12/111,369 patent/US7863255B2/en active Active
-
2009
- 2009-04-28 AU AU2009240908A patent/AU2009240908B2/en active Active
- 2009-04-28 WO PCT/JP2009/058725 patent/WO2009133963A1/en not_active Ceased
- 2009-04-28 EP EP09738900.1A patent/EP2268287B1/en active Active
- 2009-04-28 PL PL09738900T patent/PL2268287T3/pl unknown
- 2009-04-28 ES ES09738900.1T patent/ES2467968T3/es active Active
- 2009-04-28 JP JP2010535152A patent/JP5570429B2/ja active Active
- 2009-04-28 DK DK09738900.1T patent/DK2268287T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2630002T5 (es) | Fármaco anticanceroso que contiene alfa,alfa,alfa-trifluorotimidina e inhibidor de timidina fosforilasa | |
| ES2424476T3 (es) | Nanopartículas cargadas con fármaco antitumoral quimioterápico | |
| EA201170018A1 (ru) | Разагилин для изменения течения болезни паркинсона | |
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| JP2013541583A5 (enExample) | ||
| HRP20211293T1 (hr) | Pripravci za potporu pri svakodnevnim aktivnostima | |
| JP2012521435A5 (enExample) | ||
| HRP20110578T1 (hr) | Kombinacije za liječenje bolesti koje uključuju proliferaciju stanica | |
| JP2016517888A5 (enExample) | ||
| JP2009545620A5 (enExample) | ||
| JP2012517449A5 (enExample) | ||
| NZ595127A (en) | Stable pharmaceutical composition for atherosclerosis | |
| ES3032941T3 (en) | Treatment of hyperinflammatory syndrome | |
| JP2017526695A5 (enExample) | ||
| JP2014508758A5 (enExample) | ||
| JP2008514577A5 (enExample) | ||
| JP2011518761A5 (enExample) | ||
| JP2006514681A5 (enExample) | ||
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| JP2011500589A5 (enExample) | ||
| JP2012526099A5 (enExample) | ||
| HRP20191322T1 (hr) | Antitumorska kombinacija koja sadži kabazitaksel i cisplatin | |
| FI3919060T3 (fi) | Ecopipam touretten oireyhtymän hoitoon | |
| IL291574B2 (en) | Methods for using 5-Adenosine Diphosphate Ribose (ADPR) | |
| ES2842376T3 (es) | Composición farmacéutica con capecitabina, gimeracil y oteracil para tratar el cáncer, y uso de la misma |